Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency
Open Access
Abstract
Gynaecological cancers are attributed to the second most diagnosed cancers in women after breast cancer. On a global scale, cervical cancer is the fourth most common cancer and the most common cancer in developing countries with rapidly increasing mortality rates. Human papillomavirus (HPV) infection is a major contributor to the disease. HPV infections cause prominent cellular changes including alternative splicing to drive malignant transformation. A fundamental characteristic attributed to cancer is the dysregulation of cellular transcription. Alternative splicing is regulated by several splicing factors and molecular changes in these factors lead to cancer mechanisms such as tumour development and progression and drug resistance. The serine/arginine-rich (SR) proteins and heterogeneous ribonucleoproteins (hnRNPs) have prominent roles in modulating alternative splicing. Evidence shows molecular alteration and expression levels in these splicing factors in cervical cancer. Furthermore, aberrant splicing events in cancer-related genes lead to chemo- and radioresistance. Identifying clinically relevant modifications in alternative splicing events and splicing variants, in cervical cancer, as potential biomarkers for their role in cancer progression and therapy resistance is scrutinised. This review will focus on the molecular mechanisms underlying the aberrant splicing events in cervical cancer that may serve as potential biomarkers for diagnosis, prognosis, and novel drug targets.Keywords
Funding Information
- South African Medical Research Council (23108)
This publication has 105 references indexed in Scilit:
- Functions of Heterogeneous Nuclear Ribonucleoproteins in Stem Cell Potency and DifferentiationBioMed Research International, 2013
- Control of the Papillomavirus Early-to-Late Switch by Differentially Expressed SRp20Journal of Virology, 2009
- The SR protein family of splicing factors: master regulators of gene expressionBiochemical Journal, 2008
- Splicing regulation: From a parts list of regulatory elements to an integrated splicing codeRNA, 2008
- Cervical Cancer Prevention—Cervical Screening: Science in EvolutionObstetrics and Gynecology Clinics of North America, 2007
- Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteinsCancer Science, 2007
- The gene encoding the splicing factor SF2/ASF is a proto-oncogeneNature Structural & Molecular Biology, 2007
- Enhancement of the radiosensitivity of cervical cancer cells by overexpressing p73αMolecular Cancer Therapeutics, 2006
- Human Papillomavirus and Cervical CancerClinical Microbiology Reviews, 2003
- Increased expression of a COOH‐truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cellsInternational Journal of Cancer, 2002